Effect on the fetus of maternal infection with lymphocytic choriomeningitis (LCM) virus.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D004481:Ectromelia virus / Q000472:pathogenicity; D005260:Female; D005313:Fetal Death; D005315:Fetal Diseases / Q000209:etiology; D005455:Fluorescent Antibody Technique; D006086:Graft vs Host Disease / Q000209:etiology; D007108:Immune Tolerance; D008107:Liver Diseases / Q000209:etiology; D008216:Lymphocytic Choriomeningitis; D008217:Lymphocytic choriomeningitis virus / Q000472:pathogenicity; D008431:Maternal-Fetal Exchange; D051379:Mice; D010920:Placenta / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D051381:Rats; D013997:Time Factors; D014713:Viruses, Unclassified / Q000472:pathogenicity*; D005719:gamma-Globulins
D000961:Antilymphocyte Serum; D005719:gamma-Globulins